Prosecution Insights
Last updated: August 30, 2026
Application No. 18/613,922

ACTIVE MATERIAL FOR LITHIUM-ION BATTERIES AND LITHIUM-ION BATTERY

Non-Final OA §102§103
Filed
Mar 22, 2024
Priority
May 16, 2023 — JP 2023-080975
Examiner
MCNEIL, JENNIFER C
Art Unit
Tech Center
Assignee
Toyota Motor Corporation
OA Round
1 (Non-Final)
22%
Grant Probability
At Risk
1-2
OA Rounds
9m
Est. Remaining
37%
With Interview

Examiner Intelligence

Grants only 22% of cases
22%
Career Allowance Rate
19 granted / 86 resolved
-37.9% vs TC avg
Strong +15% interview lift
Without
With
+15.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
48 currently pending
Career history
135
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
46.9%
+6.9% vs TC avg
§102
22.8%
-17.2% vs TC avg
§112
26.0%
-14.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 86 resolved cases

Office Action

§102 §103
Conclusion Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-4 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by US 2015/0376016 (Krishna) (cited on IDS filed 12/10/2024). Krishna discloses that silicon clathrates are actively being investigated as anode materials for lithium-ion batteries due to their high charge storage capacity [0004] and discloses a material comprising type I and type II silicon clathrates. Specifically, the material may comprise a phase fraction about 80 wt. % to about 95 wt. % of the type II silicon clathrate. and also include between about 3 wt. % to about 10 wt. % of type I silicon clathrate [0039]. A specific example in Table 1 cites 89.7 wt% type II and 3.5 wt% type I which provides a ratio of type I to type II of 3.9%. This ratio falls within the range of claims 1 and 2. The mass of the type I clathrate is 3.5 which falls within the range of claim 3. Regarding claim 4, clathrates have an open framework forming cages which allows for gas transportation and storage [0005-0006]. Thus, the material is considered porous. The recitation “for lithium-ion batteries” in the preamble is not seen to provide any further structural limitation to the material claimed. The material disclosed by Krishna is capable of said use. Claim(s) 1, 3, 4 and 5 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by US 2015/0380724 (Chan) (cited on IDS filed 08/06/2024). Chan discloses an anode comprising type II and type I silicon clathrate [0045]. In an example, a product is formed having 80% type II and 20% type I, resulting a ratio of 25% falling in the ranges of claims 1 and 3 [0032]. Regarding claim 4, clathrates have an open framework forming cages which allows for gas transportation and storage [0044-0045]. Thus, the material is considered porous. Regarding claim 5, as stated above, Chan discloses the material is used as an anode for a rechargeable battery and discloses a lithium-ion battery ([0025], claims 14 and 15 of Chan). Claim(s) 1-4 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Horie, “Controlled thermal decomposition of NaSi to derive silicon clathrate compounds”, Journal of Solid State Chemistry, 2009 (Horie). Horie discloses formation of a material comprising type I and type II silicon clathrate. Example #450 comprises 92.5wt% type II and 7.5wt% type I resulting in a ratio of type I to type II of 8% which falls within the ranges of claims 1-3. Example #500 comprises 85.9wt% type II and 11.2wt% type I giving a ratio of type I to type II of 13%. Horie concludes that optimal conditions for forming type II silicon clathrate with minimal contamination with type I phase is performed by thermally decomposing NaSi below 440C with rapid removal of Na (conclusions). Regarding claim 4, clathrates have an open framework forming cages which allows for gas transportation and storage, thus are considered porous. The recitation “for lithium-ion batteries” in the preamble is not seen to provide any further structural limitation to the material claimed. The material disclosed by Horie is capable of said use. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 2 is rejected under 35 U.S.C. 103 as being unpatentable over US 2015/0380724 (Chan) (cited on IDS filed 08/06/2024) in view of US 2015/0376016 (Krishna) (cited on IDS filed 12/10/2024). Chan does not disclose a narrower ratio of the type I silicon clathrate to type II silicon clathrate. Krishna discloses that silicon clathrates are actively being investigated as anode materials for lithium-ion batteries due to their high charge storage capacity [0004] and discloses a material comprising type I and type II silicon clathrates. Specifically, the material may comprise a phase fraction about 80 wt. % to about 95 wt. % of the type II silicon clathrate. and also include between about 3 wt. % to about 10 wt. % of type I silicon clathrate [0039]. A specific example in Table 1 cites 89.7 wt% type II and 3.5 wt% type I which provides a ratio of type I to type II of 3.9%. This ratio falls within the range of claims 1 and 2. It would have been obvious to use the material of Krishna as the anode material of Chan with a reasonable expectation of successfully forming an anode for use in a lithium-ion battery as Krishna recognizes that silicon clathrates have a high charge storage capacity and Chan discloses a material comprising both phases are usable as an anode material. Claim(s) 5 is rejected under 35 U.S.C. 103 as being unpatentable over US 2015/0376016 (Krishna) (cited on IDS filed 12/10/2024). Krishna discloses that silicon clathrates are actively being investigated as anode materials for lithium-ion batteries due to their high charge storage capacity [0004] and discloses a material comprising type I and type II silicon clathrates as discussed above. Krishna does not give an example where the material is provided in a battery as the negative electrode layer, but does disclose that silicon clathrates are being investigated as anode materials due to their high charge storage capacity. Thus, it would have been obvious to one of ordinary skill to provide the material in the form of an anode in a battery, specifically lithium-ion, as this use is clearly suggested by Krishna and expressly due to the known property of high charge storage capacity. Claim(s) 5 is rejected under 35 U.S.C. 103 as being unpatentable over Horie, “Controlled thermal decomposition of NaSi to derive silicon clathrate compounds”, Journal of Solid State Chemistry, 2009 (Horie) in view of US 2015/0380724 (Chan) (cited on IDS filed 08/06/2024). Horie discloses a silicon clathrate material as disclosed above, but does not disclose its use as an anode for a battery. Chen discloses that it is known to use clathrates, including type I and type II, as anode active materials in a lithium-ion battery. It would have been obvious to use the silicon clathrate material of Horie as an anode material as suggested by Chan with a reasonable expectation of providing an anode capable of use in a lithium-ion battery. Horie discloses a similar content of type I and type II silicon clathrates to Chan, thus one of ordinary skill would have reasonably expected that the material of Horie can be used in a similar manner with success. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JENNIFER C MCNEIL whose telephone number is (571)272-1540. The examiner can normally be reached M-F 9-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Tong Guo can be reached at 5712723066. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. JENNIFER C. MCNEIL Primary Examiner Art Unit 1723 /Jennifer McNeil/ Primary Examiner, Art Unit 1723
Read full office action

Prosecution Timeline

Mar 22, 2024
Application Filed
Aug 11, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12677854
EGG REPLACEMENT FOOD PRODUCT AND METHOD OF PRODUCING THEREOF COMPRISING MICROBIAL PROTEIN BIOMASS
2y 9m to grant Granted Jul 14, 2026
Patent 12667125
PROCESS FOR HEAT-TREATING ONIONS
2y 9m to grant Granted Jun 30, 2026
Patent 12626803
INDIVIDUALIZED ANIMAL MIXED FOOD COMPOSITION
3y 0m to grant Granted May 12, 2026
Patent 12616218
BREAST MILK STRUCTURED LIPID SIMULATING THE COMPOSITION OF TRIGLYCERIDES AND METHOD FOR PREPARING THE SAME
2y 9m to grant Granted May 05, 2026
Patent 12588687
A MICROBIAL CELL PRODUCT, METHOD FOR OBTAINING SAID MICROBIAL CELL PRODUCT AND USE OF SAID MICROBIAL CELL PRODUCT
3y 0m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
22%
Grant Probability
37%
With Interview (+15.3%)
3y 2m (~9m remaining)
Median Time to Grant
Low
PTA Risk
Based on 86 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month